Zydus Lifesciences LimitedNSE: ZYDUSLIFE

Press Release Aug 23 2021

· Issued by Zydus Lifesciences Limited

Filed with NSE ·

On 6ix: 6ix.com/news/press-release-aug-23-2021-3

Cadila Healthcare Limited has informed the Exchange regarding a press release dated August 23, 2021, titled "Zydus Cadila gets 180-day exclusivity for Tofacitinib extended-release 22 mg tablets".

View Attachment

6ix hasn’t read this filing yet.

Zydus Lifesciences Limited on 6ix

Earlier from Zydus Lifesciences

Later from Zydus Lifesciences

All Zydus Lifesciences news releases